USNA — USANA HEALTH SCIENCES INC
—
NYSE ·
Materials ·
Chemicals ·
CIK 896264 ·
Last close
$14.50
Market Cap
$267.91M
52W High
$28.56
52W Low
$12.57
ADV30
208,553
Next earnings
2026-10-21
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | — | — | — | — | — | — | — |
| Mar 2026 | — | — | — | — | — | — | — |
| Dec 2025 | 226,200,000 | 176,792,000 | 17,249,000 | -1,775,000 | 742,915,000 | 158,380,000 | 156,643,000 |
| Sep 2025 | 213,670,000 | 164,855,000 | 1,224,000 | -6,522,000 | 726,591,000 | 145,349,000 | 145,038,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$16,626,000
Investing CF
$-8,847,000
Financing CF
$-29,777,000
CapEx
$-13,665,000
Dividends Paid
—
Buybacks
$-15,207,000
EPS Diluted TTM
$-1.21
As of
2026-08-16
Balance + Analyst (yfinance extras)
Retained Earnings
$473,235,000
Inventory
$96,358,000
Receivables
$9,657,000
ST Investments
—
EBIT TTM
$40,924,000
Pretax Income TTM
$40,253,000
Interest Exp TTM
$671,000
Analysts
1
Yahoo Snapshot (yfinance, live)
Total Revenue
$913,361,024
EBITDA
$73,919,000
Free Cash Flow
$49,128,500
Enterprise Value
$153,624,544
Total Cash
$168,560,000
Total Debt
$0
Shares Out
18,476,534
Trailing EPS
$-1.18
Book Value
$28.51
ROE
-5.1%
ROA
3.6%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 925,257,000 | 50,862,000 | 10,760,000 | 742,915,000 | 156,643,000 | 533,104,000 | 22,349,000 |
| Dec 2024 | 854,503,000 | 66,324,000 | 42,030,000 | 748,193,000 | 161,861,000 | 532,109,000 | 60,992,000 |
| Dec 2023 | 921,010,000 | 93,071,000 | 63,788,000 | 632,757,000 | 135,555,000 | 497,202,000 | 70,641,000 |
| Dec 2022 | 998,601,000 | 107,614,000 | 69,350,000 | 596,549,000 | 162,077,000 | 434,472,000 | 103,902,000 |
TTM Snapshot
Revenues TTM
$896,425,000
NetIncome TTM
$46,285,000
OpCashFlow TTM
$0
Assets (Latest)
$742,915,000
Forward EPS
$1.77
Max Pain — expiry 2027-01-15 (volume-derived — Yahoo OI feed degraded)
max pain strike: $12.50 · spot: $14.82 · call volume: 205 · put volume: 156
Expected Move to 2027-01-15:
±$3.72
(25.13%) —
implied range
$11.09 –
$18.54
· ATM straddle on $15.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| BAK | BRASKEM SA | $265.70M | $1.54 | — |
| CRLBF | Cresco Labs Inc. | $271.67M | $0.76 | — |
| ACB | AURORA CANNABIS INC | $259.57M | $4.10 | — |
| ALTO | Alto Ingredients, Inc. | $289.33M | $3.73 | — |
| LTBR | LIGHTBRIDGE Corp | $241.37M | $6.85 | — |
News headlines (Yahoo Finance, 1h cache)
Implied Volatility Surging for USANA Health Stock Options
2026-09-14 17:54 · Yahoo
1 Stock Under $50 to Target This Week and 2 We Brush Off
2026-09-12 00:27 · Yahoo
USANA CEO Kevin Guest Calls on People to Find a Way to Serve Others, Then Act
2026-09-01 11:06 · Yahoo
Reflecting On Personal Care Stocks’ Q2 Earnings: USANA (NYSE:USNA)
2026-08-31 15:58 · Yahoo
USANA Introduces 3-in-1 Protein, Creatine, and Electrolyte Drink Mix
2026-08-17 11:13 · Yahoo
3 Small-Cap Stocks We Find Risky
2026-08-16 15:41 · Yahoo
5 Must-Read Analyst Questions From USANA’s Q2 Earnings Call
2026-08-13 01:49 · Yahoo
USANA (USNA) Q2 2026 Earnings Call Transcript
2026-08-12 00:31 · Yahoo
Why Usana Health Sciences Stock Plummeted This Week
2026-08-09 16:48 · Yahoo
Should USANA Health Sciences (USNA) Revisit Its Valuation After Lowered Guidance And Q2 Loss?
2026-08-06 10:14 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.